Saol Therapeutics

Saol Therapeutics company information, Employees & Contact Information

Saol Therapeutics (pronounced "Sail") is a privately held, clinical-stage, pharmaceutical company with operations in Roswell, GA, Dublin, Ireland and Hamilton, Bermuda. The company is focused on development activity in CNS disorders such as pain management and spasticity and orphan diseases. Saol is committed to providing and advancing therapeutic options for patients and the physicians treating these populations and currently has two Phase 2 trials and one Phase 3 trail underway in the United States.

Company Details

Employees
41
Founded
-
Address
1000 Holcomb Woods Parkway, Suite 270,ireland
Phone
770-274-2470
Email
bd****@****lrx.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Website
saolrx.com
HQ
Roswell, GA
Looking for a particular Saol Therapeutics employee's phone or email?

Saol Therapeutics Questions

News

/C O R R E C T I O N -- Saol Therapeutics/ - Yahoo Finance

/C O R R E C T I O N -- Saol Therapeutics/ Yahoo Finance

Saol Therapeutics Announces Major Clinical Milestones Across Multiple Development Programs - PR Newswire

Saol Therapeutics Announces Major Clinical Milestones Across Multiple Development Programs PR Newswire

Saol Therapeutics Announces Poster Presentation at the UMDF Mitochondrial Medicine 2025 Conference - The AI Journal

Saol Therapeutics Announces Poster Presentation at the UMDF Mitochondrial Medicine 2025 Conference The AI Journal

Saol Therapeutics Announces CDC has Updated Information Related to Use and Availability of VARIZIG® (Varicella Zoster Immune Globulin [Human]) - PRWeb

Saol Therapeutics Announces CDC has Updated Information Related to Use and Availability of VARIZIG® (Varicella Zoster Immune Globulin [Human]) PRWeb

Saol Therapeutics announces FDA acceptance of New Drug Application for SL1009 for treatment of Pyruvate Dehydrogenase Complex Deficiency - PR Newswire

Saol Therapeutics announces FDA acceptance of New Drug Application for SL1009 for treatment of Pyruvate Dehydrogenase Complex Deficiency PR Newswire

Saol Therapeutics Announces Positive Topline Results from the SL-1002 RAISE Limb Spasticity Trial - PR Newswire

Saol Therapeutics Announces Positive Topline Results from the SL-1002 RAISE Limb Spasticity Trial PR Newswire

Top Saol Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant